Literature DB >> 99321

The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines.

B B Vargaftig.   

Abstract

Salicylic acid, 1,10- and 1,7-phenanthroline prevented inhibition by aspirin of platelet aggregation and of generation of thromboxane A2 due to arachidonic acid, to the ionophore A21387, to thrombin and to collagen. Dithiothreitol, another drug which prevents aggregation and formation of thromboxane A2, but only reversibly, failed to interfere with the inhibition by aspirin. Irreversible inhibition by indomethacin and by the substrate analogue 5,8,11,14-tetraynoic acid was also unaffected by salicylic acid or by 1,10-phenanthroline, which thus probably exert a specific interaction with the aspirin-binding site. Inactivation of platelet cyclo-oxygenase with arachidonic acid led to inhibition of the formation of thromboxane A2 and of aggregation due to arachidonic acid itself and to collagen, but barely affected aggregation by thrombin, even though generation of thromboxane A2 was blocked. Use of salicylic acid and of reversible inhibitors of cyclo-oxygenase may help to unravel the mechanism of inhibition due to other agents.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99321     DOI: 10.1016/0014-2999(78)90355-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.

Authors:  B Rosenkranz; C Fischer; C O Meese; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

2.  Multiple sites on prostaglandin cyclooxygenase are determinants in the action of nonsteroidal antiinflammatory agents.

Authors:  J L Humes; C A Winter; S J Sadowski; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

3.  Proceedings of the British Pharmacological Society. 17th-19th December, 1979: University of London (Institute of Education).

Authors: 
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

4.  A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding time.

Authors:  R A Seymour; F M Williams; A Oxley; A Ward; M Fearns; K Brighan; M D Rawlins; P M Jones
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 5.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

6.  Systemic availability of acetylsalicylic acid in normal men and women and its effect on in vitro platelet aggregability.

Authors:  S E Husted; A K Pedersen; T Petersen; E Geday
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  [Effects of acetylsalicylic acid on partial functions of human thrombocytes are not inhibited in vivo by salicylic acid].

Authors:  R Simrock; V Lischke; A Missalla; P Schwidtal; H K Breddin
Journal:  Klin Wochenschr       Date:  1984-03-01

8.  Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.

Authors:  E Dejana; C Cerletti; C de Castellarnau; M Livio; F Galletti; R Latini; G de Gaetano
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Mechanisms of Forssman-induced bronchospasm and their inhibition.

Authors:  K D Butler; J R Smith
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

10.  Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.

Authors:  B Brantmark; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.